These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 20974297)

  • 1. Pseudophosphorylation of tau protein directly modulates its aggregation kinetics.
    Chang E; Kim S; Schafer KN; Kuret J
    Biochim Biophys Acta; 2011 Feb; 1814(2):388-95. PubMed ID: 20974297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-specific pseudophosphorylation modulates the rate of tau filament dissociation.
    Necula M; Kuret J
    FEBS Lett; 2005 Feb; 579(6):1453-7. PubMed ID: 15733856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic missense MAPT mutations differentially modulate tau aggregation propensity at nucleation and extension steps.
    Chang E; Kim S; Yin H; Nagaraja HN; Kuret J
    J Neurochem; 2008 Nov; 107(4):1113-23. PubMed ID: 18803694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudophosphorylation and glycation of tau protein enhance but do not trigger fibrillization in vitro.
    Necula M; Kuret J
    J Biol Chem; 2004 Nov; 279(48):49694-703. PubMed ID: 15364924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for an intermediate in tau filament formation.
    Chirita CN; Kuret J
    Biochemistry; 2004 Feb; 43(6):1704-14. PubMed ID: 14769048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hsp70 alters tau function and aggregation in an isoform specific manner.
    Voss K; Combs B; Patterson KR; Binder LI; Gamblin TC
    Biochemistry; 2012 Jan; 51(4):888-98. PubMed ID: 22236337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudo-phosphorylation of tau at Ser202 and Thr205 affects tau filament formation.
    Rankin CA; Sun Q; Gamblin TC
    Brain Res Mol Brain Res; 2005 Jul; 138(1):84-93. PubMed ID: 15913837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potency of a tau fibrillization inhibitor is influenced by its aggregation state.
    Congdon EE; Necula M; Blackstone RD; Kuret J
    Arch Biochem Biophys; 2007 Sep; 465(1):127-35. PubMed ID: 17559794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating triggers and enhancers of tau fibrillization.
    Kuret J; Congdon EE; Li G; Yin H; Yu X; Zhong Q
    Microsc Res Tech; 2005 Jul; 67(3-4):141-55. PubMed ID: 16103995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggregation analysis of the microtubule binding domain in tau protein by spectroscopic methods.
    Yao TM; Tomoo K; Ishida T; Hasegawa H; Sasaki M; Taniguchi T
    J Biochem; 2003 Jul; 134(1):91-9. PubMed ID: 12944375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyanine dye N744 inhibits tau fibrillization by blocking filament extension: implications for the treatment of tauopathic neurodegenerative diseases.
    Necula M; Chirita CN; Kuret J
    Biochemistry; 2005 Aug; 44(30):10227-37. PubMed ID: 16042400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine 394 is phosphorylated in Alzheimer's paired helical filament tau and in fetal tau with c-Abl as the candidate tyrosine kinase.
    Derkinderen P; Scales TM; Hanger DP; Leung KY; Byers HL; Ward MA; Lenz C; Price C; Bird IN; Perera T; Kellie S; Williamson R; Noble W; Van Etten RA; Leroy K; Brion JP; Reynolds CH; Anderton BH
    J Neurosci; 2005 Jul; 25(28):6584-93. PubMed ID: 16014719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments.
    Barghorn S; Mandelkow E
    Biochemistry; 2002 Dec; 41(50):14885-96. PubMed ID: 12475237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. O-GlcNAc modification of tau directly inhibits its aggregation without perturbing the conformational properties of tau monomers.
    Yuzwa SA; Cheung AH; Okon M; McIntosh LP; Vocadlo DJ
    J Mol Biol; 2014 Apr; 426(8):1736-52. PubMed ID: 24444746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative characterization of heparin binding to Tau protein: implication for inducer-mediated Tau filament formation.
    Zhu HL; Fernández C; Fan JB; Shewmaker F; Chen J; Minton AP; Liang Y
    J Biol Chem; 2010 Feb; 285(6):3592-3599. PubMed ID: 19959468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathways of tau fibrillization.
    Kuret J; Chirita CN; Congdon EE; Kannanayakal T; Li G; Necula M; Yin H; Zhong Q
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):167-78. PubMed ID: 15615636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The core of tau-paired helical filaments studied by scanning transmission electron microscopy and limited proteolysis.
    von Bergen M; Barghorn S; Müller SA; Pickhardt M; Biernat J; Mandelkow EM; Davies P; Aebi U; Mandelkow E
    Biochemistry; 2006 May; 45(20):6446-57. PubMed ID: 16700555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudophosphorylation of tau protein alters its ability for self-aggregation.
    Haase C; Stieler JT; Arendt T; Holzer M
    J Neurochem; 2004 Mar; 88(6):1509-20. PubMed ID: 15009652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of cysteines in accelerating Tau filament formation.
    Chidambaram H; Chinnathambi S
    J Biomol Struct Dyn; 2022 Jul; 40(10):4366-4375. PubMed ID: 33317395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein anatomy: C-tail region of human tau protein as a crucial structural element in Alzheimer's paired helical filament formation in vitro.
    Yanagawa H; Chung SH; Ogawa Y; Sato K; Shibata-Seki T; Masai J; Ishiguro K
    Biochemistry; 1998 Feb; 37(7):1979-88. PubMed ID: 9485325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.